1
|
Rebelatto CLK, Boldrini-Leite LM, Daga DR, Marsaro DB, Vaz IM, Jamur VR, de Aguiar AM, Vieira TB, Furman BP, Aguiar CO, Brofman PRS. Quality Control Optimization for Minimizing Security Risks Associated with Mesenchymal Stromal Cell-Based Product Development. Int J Mol Sci 2023; 24:12955. [PMID: 37629136 PMCID: PMC10455270 DOI: 10.3390/ijms241612955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2023] [Revised: 08/09/2023] [Accepted: 08/15/2023] [Indexed: 08/27/2023] Open
Abstract
Mesenchymal stromal cells (MSCs) have been considered a therapeutic strategy in regenerative medicine because of their regenerative and immunomodulatory properties. The translation of MSC-based products has some challenges, such as regulatory and scientific issues. Quality control should be standardized and optimized to guarantee the reproducibility, safety, and efficacy of MSC-based products to be administered to patients. The aim of this study was to develop MSC-based products for use in clinical practice. Quality control assays include cell characterization, cell viability, immunogenicity, and cell differentiation; safety tests such as procoagulant tissue factor (TF), microbiological, mycoplasma, endotoxin, genomic stability, and tumorigenicity tests; and potency tests. The results confirm that the cells express MSC markers; an average cell viability of 96.9%; a low expression of HLA-DR and costimulatory molecules; differentiation potential; a high expression of TF/CD142; an absence of pathogenic microorganisms; negative endotoxins; an absence of chromosomal abnormalities; an absence of genotoxicity and tumorigenicity; and T-lymphocyte proliferation inhibition potential. This study shows the relevance of standardizing the manufacturing process and quality controls to reduce variability due to the heterogeneity between donors. The results might also be useful for the implementation and optimization of new analytical techniques and automated methods to improve safety, which are the major concerns related to MSC-based therapy.
Collapse
Affiliation(s)
- Carmen Lúcia Kuniyoshi Rebelatto
- Core for Cell Technology, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Brazil; (L.M.B.-L.); (D.R.D.); (D.B.M.); (I.M.V.); (V.R.J.); (T.B.V.); (B.P.F.); (C.O.A.); (P.R.S.B.)
- National Institute of Science and Technology for Regenerative Medicine—INCT-REGENERA, Rio de Janeiro 21941-599, Brazil
| | - Lidiane Maria Boldrini-Leite
- Core for Cell Technology, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Brazil; (L.M.B.-L.); (D.R.D.); (D.B.M.); (I.M.V.); (V.R.J.); (T.B.V.); (B.P.F.); (C.O.A.); (P.R.S.B.)
- National Institute of Science and Technology for Regenerative Medicine—INCT-REGENERA, Rio de Janeiro 21941-599, Brazil
| | - Debora Regina Daga
- Core for Cell Technology, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Brazil; (L.M.B.-L.); (D.R.D.); (D.B.M.); (I.M.V.); (V.R.J.); (T.B.V.); (B.P.F.); (C.O.A.); (P.R.S.B.)
- National Institute of Science and Technology for Regenerative Medicine—INCT-REGENERA, Rio de Janeiro 21941-599, Brazil
| | - Daniela Boscaro Marsaro
- Core for Cell Technology, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Brazil; (L.M.B.-L.); (D.R.D.); (D.B.M.); (I.M.V.); (V.R.J.); (T.B.V.); (B.P.F.); (C.O.A.); (P.R.S.B.)
- National Institute of Science and Technology for Regenerative Medicine—INCT-REGENERA, Rio de Janeiro 21941-599, Brazil
| | - Isadora May Vaz
- Core for Cell Technology, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Brazil; (L.M.B.-L.); (D.R.D.); (D.B.M.); (I.M.V.); (V.R.J.); (T.B.V.); (B.P.F.); (C.O.A.); (P.R.S.B.)
- National Institute of Science and Technology for Regenerative Medicine—INCT-REGENERA, Rio de Janeiro 21941-599, Brazil
| | - Valderez Ravaglio Jamur
- Core for Cell Technology, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Brazil; (L.M.B.-L.); (D.R.D.); (D.B.M.); (I.M.V.); (V.R.J.); (T.B.V.); (B.P.F.); (C.O.A.); (P.R.S.B.)
- National Institute of Science and Technology for Regenerative Medicine—INCT-REGENERA, Rio de Janeiro 21941-599, Brazil
| | - Alessandra Melo de Aguiar
- Laboratory of Basic Biology of Stem Cells, Carlos Chagas Institute—Fiocruz-Paraná, Curitiba 81350-010, Brazil;
| | - Thalita Bastida Vieira
- Core for Cell Technology, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Brazil; (L.M.B.-L.); (D.R.D.); (D.B.M.); (I.M.V.); (V.R.J.); (T.B.V.); (B.P.F.); (C.O.A.); (P.R.S.B.)
| | - Bianca Polak Furman
- Core for Cell Technology, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Brazil; (L.M.B.-L.); (D.R.D.); (D.B.M.); (I.M.V.); (V.R.J.); (T.B.V.); (B.P.F.); (C.O.A.); (P.R.S.B.)
| | - Cecília Oliveira Aguiar
- Core for Cell Technology, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Brazil; (L.M.B.-L.); (D.R.D.); (D.B.M.); (I.M.V.); (V.R.J.); (T.B.V.); (B.P.F.); (C.O.A.); (P.R.S.B.)
| | - Paulo Roberto Slud Brofman
- Core for Cell Technology, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Brazil; (L.M.B.-L.); (D.R.D.); (D.B.M.); (I.M.V.); (V.R.J.); (T.B.V.); (B.P.F.); (C.O.A.); (P.R.S.B.)
- National Institute of Science and Technology for Regenerative Medicine—INCT-REGENERA, Rio de Janeiro 21941-599, Brazil
| |
Collapse
|
2
|
Vialle EN, Fracaro L, Barchiki F, Dominguez AC, Arruda ADO, Olandoski M, Brofman PRS, Kuniyoshi Rebelatto CL. Human Adipose-Derived Stem Cells Reduce Cellular Damage after Experimental Spinal Cord Injury in Rats. Biomedicines 2023; 11:biomedicines11051394. [PMID: 37239065 DOI: 10.3390/biomedicines11051394] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Revised: 04/28/2023] [Accepted: 04/28/2023] [Indexed: 05/28/2023] Open
Abstract
Traumatic spinal cord injury (SCI) is a devastating condition without an effective therapy. Cellular therapies are among the promising treatment strategies. Adult stem cells, such as mesenchymal stem cells, are often used clinical research for their immunomodulatory and regenerative potential. This study aimed to evaluate the effect of human adipose tissue-derived stem cells (ADSC) infusion through the cauda equina in rats with SCI. The human ADSC from bariatric surgery was isolated, expanded, and characterized. Wistar rats were subjected to blunt SCI and were divided into four groups. Two experimental groups (EG): EG1 received one ADSC infusion after SCI, and EG2 received two infusions, the first one after SCI and the second infusion seven days after the injury. Control groups (CG1 and CG2) received infusion with a culture medium. In vivo, cell tracking was performed 48 h and seven days after ADSC infusion. The animals were followed up for 40 days after SCI, and immunohistochemical quantification of myelin, neurons, and astrocytes was performed. Cellular tracking showed cell migration towards the injury site. ADSC infusion significantly reduced neuronal loss, although it did not prevent the myelin loss or enhance the area occupied by astrocytes compared to the control group. The results were similar when comparing one or two cell infusions. The injection of ADSC distal to the injured area was shown to be a safe and effective method for cellular administration in spinal cord injury.
Collapse
Affiliation(s)
- Emiliano Neves Vialle
- Spine Surgery Group, Cajuru University Hospital, Pontifícia Universidade Católica do Paraná, Curitiba 80215-030, Brazil
| | - Letícia Fracaro
- Core for Cell Technology, School of Medicine and Life Sciences, Pontifícia Universidade Católica do Paraná, Curitiba 80215-030, Brazil
- National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Rio de Janeiro 21941-599, Brazil
| | - Fabiane Barchiki
- Core for Cell Technology, School of Medicine and Life Sciences, Pontifícia Universidade Católica do Paraná, Curitiba 80215-030, Brazil
- National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Rio de Janeiro 21941-599, Brazil
| | - Alejandro Correa Dominguez
- Laboratory of Basic Biology of Stem Cells, Carlos Chagas Institute-Fiocruz, Rio de Janeiro 21941-599, Brazil
| | - André de Oliveira Arruda
- Spine Surgery Group, Cajuru University Hospital, Pontifícia Universidade Católica do Paraná, Curitiba 80215-030, Brazil
| | - Marcia Olandoski
- Department of Biostatistics, School of Medicine, Catholic University of Paraná, Curitiba 80215-030, Brazil
| | - Paulo Roberto Slud Brofman
- Core for Cell Technology, School of Medicine and Life Sciences, Pontifícia Universidade Católica do Paraná, Curitiba 80215-030, Brazil
- National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Rio de Janeiro 21941-599, Brazil
| | - Carmen Lúcia Kuniyoshi Rebelatto
- Core for Cell Technology, School of Medicine and Life Sciences, Pontifícia Universidade Católica do Paraná, Curitiba 80215-030, Brazil
- National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Rio de Janeiro 21941-599, Brazil
| |
Collapse
|
3
|
Oliveira Pereira C, Pillonetto DV, Borgonovo T, Rebelatto CLK, Barbosa ML, Finger MC, Nichele S, Trennepohl J, Loth G, Bonfim C. Somatic mosaicism in patients with Fanconi anaemia: Proposal of alternative tissue for inconclusive diagnoses. Int J Lab Hematol 2022; 44:900-906. [PMID: 35644995 DOI: 10.1111/ijlh.13874] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2022] [Accepted: 04/23/2022] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Fanconi anaemia (FA) is a rare genetic disorder marked by progressive bone marrow failure, chromosomal fragility, and increased cancer susceptibility. Laboratory diagnosis includes chromosomal instability test and mutation investigation. A total of 15%-25% of all patients may have somatic mosaicism, characterized by two distinct haematopoietic cell populations, one resistant and one sensitive to agents that induce chromosomal breakage, which complicates the diagnosis by a high incidence of reverted cells leading to inconclusive or false-negative results. The study aimed to evaluate the use of bone marrow stromal mesenchymal cells (BM-MSCs) as an alternative, non-haematopoietic tissue for diagnosis. METHODS Bone marrow mesenchymal stromal cells from 12 patients with positive diepoxybutane (DEB) tests were cultivated and analysed by cytogenetics and mutation investigation. RESULTS The DEB test was performed at 0.1 and 0.01 μg/ml concentrations, with an index ranging from 0.24 to 1.00. At higher concentration, the metaphases number was lower, probably due to toxicity. Regarding the molecular investigation, all the mutations previously found in peripheral blood were identified on BM-MSC. CONCLUSION This study demonstrated the possibility of using BM-MSCs as an alternative tissue for cytogenetic and molecular investigation. Future tests using an intermediate DEB concentration may lead to an optimal protocol that could be non-toxic to cells but provides conclusive results.
Collapse
Affiliation(s)
- Camila Oliveira Pereira
- Unidade Laboratório de Análises Clínicas, Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, Brazil
| | - Daniela Vandresen Pillonetto
- Unidade Laboratório de Análises Clínicas, Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, Brazil
| | - Tamara Borgonovo
- Unidade Laboratório de Análises Clínicas, Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, Brazil
| | | | - Miriam Lacerda Barbosa
- Unidade Laboratório de Análises Clínicas, Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, Brazil
| | - Maria Cristina Finger
- Unidade Laboratório de Análises Clínicas, Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, Brazil
| | - Samantha Nichele
- Unidade de Transplante de Medula Óssea, Oncologia e Hematologia do Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, Brazil
| | - Joanna Trennepohl
- Unidade de Transplante de Medula Óssea, Oncologia e Hematologia do Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, Brazil
| | - Gisele Loth
- Unidade de Transplante de Medula Óssea, Oncologia e Hematologia do Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, Brazil.,Instituto de Pesquisa Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba, Brazil
| | - Carmem Bonfim
- Unidade de Transplante de Medula Óssea, Oncologia e Hematologia do Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, Brazil.,Instituto de Pesquisa Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba, Brazil
| |
Collapse
|
4
|
Vaz IM, Borgonovo T, Kasai-Brunswick TH, Santos DSD, Mesquita FCP, Vasques JF, Gubert F, Rebelatto CLK, Senegaglia AC, Brofman PRS. Chromosomal aberrations after induced pluripotent stem cells reprogramming. Genet Mol Biol 2021; 44:e20200147. [PMID: 34496008 PMCID: PMC8425414 DOI: 10.1590/1678-4685-gmb-2020-0147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2020] [Accepted: 07/15/2021] [Indexed: 12/03/2022] Open
Abstract
Induced pluripotent stem cells (iPSCs) are generated from adult cells that have been reprogrammed to pluripotency. However, in vitro cultivation and genetic reprogramming increase genetic instability, which could result in chromosomal abnormalities. Maintenance of genetic stability after reprogramming is required for possible experimental and clinical applications. The aim of this study was to analyze chromosomal alterations by using the G-banding karyotyping method applied to 97 samples from 38 iPSC cell lines generated from peripheral blood or Wharton’s jelly. Samples from patients with long QT syndrome, Jervell and Lange-Nielsen syndrome and amyotrophic lateral sclerosis and from normal individuals revealed the following chromosomal alterations: acentric fragments, chromosomal fusions, premature centromere divisions, double minutes, radial figures, ring chromosomes, polyploidies, inversions and trisomies. An analysis of two samples generated from Wharton’s jelly before and after reprogramming showed that abnormal clones can emerge or be selected and generate an altered lineage. IPSC lines may show clonal and nonclonal chromosomal aberrations in several passages (from P6 to P34), but these aberrations are more common in later passages. Many important chromosomal aberrations were detected, showing that G-banding is very useful for evaluating genetic instability with important repercussions for the application of iPSC lines.
Collapse
Affiliation(s)
- Isadora May Vaz
- Pontifícia Universidade Católica do Paraná, Escola de Medicina, Núcleo de Tecnologia Celular, Curitiba, PR, Brazil.,Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, RJ, Brazil
| | - Tamara Borgonovo
- Pontifícia Universidade Católica do Paraná, Escola de Medicina, Núcleo de Tecnologia Celular, Curitiba, PR, Brazil.,Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, RJ, Brazil
| | - Tais Hanae Kasai-Brunswick
- Universidade Federal do Rio de Janeiro, Instituto de Biofísica Carlos Chagas Filho, Rio de Janeiro, RJ, Brazil.,Universidade Federal do Rio de Janeiro, Centro Nacional de Biologia Estrutural e Bioimagem, Rio de Janeiro, RJ, Brazil
| | - Danúbia Silva Dos Santos
- Universidade Federal do Rio de Janeiro, Instituto de Biofísica Carlos Chagas Filho, Rio de Janeiro, RJ, Brazil
| | | | - Juliana Ferreira Vasques
- Universidade Federal do Rio de Janeiro, Instituto de Biofísica Carlos Chagas Filho, Rio de Janeiro, RJ, Brazil.,Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, RJ, Brazil
| | - Fernanda Gubert
- Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, RJ, Brazil.,Instituto de Ciências Biomédicas, Rio de Janeiro, RJ, Brazil
| | - Carmen Lúcia Kuniyoshi Rebelatto
- Pontifícia Universidade Católica do Paraná, Escola de Medicina, Núcleo de Tecnologia Celular, Curitiba, PR, Brazil.,Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, RJ, Brazil
| | - Alexandra Cristina Senegaglia
- Pontifícia Universidade Católica do Paraná, Escola de Medicina, Núcleo de Tecnologia Celular, Curitiba, PR, Brazil.,Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, RJ, Brazil
| | - Paulo Roberto Slud Brofman
- Pontifícia Universidade Católica do Paraná, Escola de Medicina, Núcleo de Tecnologia Celular, Curitiba, PR, Brazil.,Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, RJ, Brazil
| |
Collapse
|
5
|
Senegaglia AC, Rebelatto CLK, Franck CL, Lima JS, Boldrini-Leite LM, Daga DR, Leitão CA, Shigunov P, de Azambuja AP, Bana E, Marsaro DB, Schaidt B, Micosky A, Jamur VR, Schluga Y, Vaz IM, Ribeiro LL, Correa A, Brofman EPRS. Combined Use of Tocilizumab and Mesenchymal Stromal Cells in the Treatment of Severe Covid-19: Case Report. Cell Transplant 2021; 30:9636897211021008. [PMID: 34074163 PMCID: PMC8175829 DOI: 10.1177/09636897211021008] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
The coronavirus pandemic is one of the most significant public health events in recent history. Currently, no specific treatment is available. Some drugs and cell-based therapy have been tested as alternatives to decrease the disease's symptoms, length of hospital stay, and mortality. We reported the case of a patient with a severe manifestation of COVID-19 in critical condition who did not respond to the standard procedures used, including six liters of O2 supplementation under a nasal catheter and treatment with dexamethasone and enoxaparin in prophylactic dose. The patient was treated with tocilizumab and an advanced therapy product based on umbilical cord-derived mesenchymal stromal cells (UC-MSC). The combination of tocilizumab and UC-MSC proved to be safe, with no adverse effects, and the results of this case report prove to be a promising alternative in the treatment of patients with severe acute respiratory syndrome due to SARS-CoV-2.
Collapse
Affiliation(s)
- Alexandra Cristina Senegaglia
- Core for Cell Technology - School of Medicine - 28100Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.,Complexo Hospital de Clínicas - 274922Universidade Federal do Paraná, Curitiba, Paraná, Brazil.,National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Brazil
| | - Carmen Lúcia Kuniyoshi Rebelatto
- Core for Cell Technology - School of Medicine - 28100Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.,Complexo Hospital de Clínicas - 274922Universidade Federal do Paraná, Curitiba, Paraná, Brazil.,National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Brazil
| | - Claudio Luciano Franck
- Complexo Hospital de Clínicas - 274922Universidade Federal do Paraná, Curitiba, Paraná, Brazil
| | | | - Lidiane Maria Boldrini-Leite
- Core for Cell Technology - School of Medicine - 28100Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.,National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Brazil
| | - Debora Regina Daga
- Core for Cell Technology - School of Medicine - 28100Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.,National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Brazil
| | - Cleverson Alex Leitão
- Complexo Hospital de Clínicas - 274922Universidade Federal do Paraná, Curitiba, Paraná, Brazil
| | - Patrícia Shigunov
- National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Brazil.,Laboratory of Basic Biology of Stem Cells - Carlos Chagas Institute - Fiocruz-Paraná, Curitiba, Paraná, Brazil
| | - Ana Paula de Azambuja
- Complexo Hospital de Clínicas - 274922Universidade Federal do Paraná, Curitiba, Paraná, Brazil
| | - Elisa Bana
- Hospital Nossa Senhora do Pilar, Curitiba, Paraná, Brazil
| | - Daniela Boscaro Marsaro
- Core for Cell Technology - School of Medicine - 28100Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.,National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Brazil
| | - Bruna Schaidt
- Core for Cell Technology - School of Medicine - 28100Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil
| | - Andressa Micosky
- Core for Cell Technology - School of Medicine - 28100Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil
| | - Valderez Ravaglio Jamur
- Core for Cell Technology - School of Medicine - 28100Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.,National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Brazil
| | - Yara Schluga
- Complexo Hospital de Clínicas - 274922Universidade Federal do Paraná, Curitiba, Paraná, Brazil
| | - Isadora May Vaz
- Core for Cell Technology - School of Medicine - 28100Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.,National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Brazil
| | | | - Alejandro Correa
- National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Brazil.,Laboratory of Basic Biology of Stem Cells - Carlos Chagas Institute - Fiocruz-Paraná, Curitiba, Paraná, Brazil
| | - E Paulo Roberto Slud Brofman
- Core for Cell Technology - School of Medicine - 28100Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.,National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Brazil
| |
Collapse
|
6
|
Dantas JR, Araújo DB, Silva KR, Souto DL, de Fátima Carvalho Pereira M, Luiz RR, Dos Santos Mantuano M, Claudio-da-Silva C, Gabbay MAL, Dib SA, Couri CEB, Maiolino A, Rebelatto CLK, Daga DR, Senegaglia AC, Brofman PRS, Baptista LS, de Oliveira JEP, Zajdenverg L, Rodacki M. Adipose tissue-derived stromal/stem cells + cholecalciferol: a pilot study in recent-onset type 1 diabetes patients. Arch Endocrinol Metab 2021; 65:342-351. [PMID: 33939911 PMCID: PMC10065343 DOI: 10.20945/2359-3997000000368] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Objective Adipose tissue-derived stromal/stem cells (ASCs) and vitamin D have immunomodulatory actions that could be useful for type 1 diabetes (T1D). We aimed in this study to investigate the safety and efficacy of ASCs + daily cholecalciferol (VIT D) for 6 months in patients with recent-onset T1D. Methods In this prospective, dual-center, open trial, patients with recent onset T1D received one dose of allogenic ASC (1 × 106 cells/kg) and cholecalciferol 2,000 UI/day for 6 months (group 1). They were compared to patients who received chol-ecalciferol (group 2) and standard treatment (group 3). Adverse events were recorded; C-peptide (CP), insulin dose and HbA1c were measured at baseline (T0), after 3 (T3) and 6 months (T6). Results In group 1 (n = 7), adverse events included transient headache (all), mild local reactions (all), tachycardia (n = 4), abdominal cramps (n = 1), thrombophlebitis (n = 4), scotomas (n = 2), and central retinal vein occlusion at T3 (n = 1, resolution at T6). Group 1 had an increase in basal CP (p = 0.018; mean: 40.41+/-40.79 %), without changes in stimulated CP after mixed meal (p = 0.62), from T0 to T6. Basal CP remained stable in groups 2 and 3 (p = 0.58 and p = 0.116, respectively). Group 1 had small insulin requirements (0.31+/- 0.26 UI/kg) without changes at T6 (p = 0.44) and HbA1c decline (p = 0.01). At T6, all patients (100%; n = 7) in group 1 were in honeymoon vs 75% (n = 3/4) and 50% (n = 3/6) in groups 2 and 3, p = 0.01. Conclusion Allogenic ASC + VIT D without immunosuppression was safe and might have a role in the preservation of β-cells in patients with recent-onset T1D. ClinicalTrials.gov: NCT03920397.
Collapse
Affiliation(s)
- Joana Rodrigues Dantas
- Departamento de Nutrologia e Diabetes, Universidade Federal do Rio de Janeiro, RJ, Brasil
| | - Débora Batista Araújo
- Departamento de Nutrologia e Diabetes, Universidade Federal do Rio de Janeiro, RJ, Brasil
| | - Karina Ribeiro Silva
- Laboratório de Bioengenharia de Tecidos, Instituto Nacional de Metrologia, Qualidade e Tecnologia (Inmetro), Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil
| | - Débora Lopes Souto
- Departamento de Nutrologia e Diabetes, Universidade Federal do Rio de Janeiro, RJ, Brasil,
| | | | - Ronir Raggio Luiz
- Instituto de Estudos de Saúde Pública, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil
| | | | - Cesar Claudio-da-Silva
- Departamento de Cirurgia Plástica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil
| | | | | | | | - Angelo Maiolino
- Departamento de Hematologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil
| | | | - Débora Regina Daga
- Core Cell Technology, Pontifícia Universidade Católica do Paraná, Curitiba, PR, Brasil
| | | | | | - Leandra S Baptista
- Centro Multidisciplinar de Pesquisas Biológicas (Numpex-Bio), Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil; Laboratório de Bioengenharia de Tecidos, Instituto Nacional de Metrologia, Qualidade e Tecnologia (Inmetro), Rio de Janeiro, RJ, Brasil
| | | | - Lenita Zajdenverg
- Departamento de Nutrologia e Diabetes, Universidade Federal do Rio de Janeiro, RJ, Brasil
| | - Melanie Rodacki
- Departamento de Nutrologia e Diabetes, Universidade Federal do Rio de Janeiro, RJ, Brasil
| |
Collapse
|
7
|
Brito HFV, Rebelatto CLK, Senegaglia AC, Borgonovo T, Fracaro L, Leite LMB, Vaz IM, Brofman PRS, Locatelli-Dittrich R. RECRUITMENT OF BONE MARROW MONONUCLEAR CELL TO THE CENTRAL NERVOUS SYSTEM AFTER ALLOGENEIC CELL TRANSPLANTATION IN DOGS WITH CANINE DISTEMPER SEQUELS. Cytotherapy 2021. [DOI: 10.1016/j.jcyt.2021.02.093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
8
|
Senegaglia AC, Rebelatto CLK, Franck CL, Lima JS, Daga DR, Shigunov P, Azambuja AP, Bana EG, Marsaro DB, Schaidt B, Micosky A, Jamur VR, Vaz IM, Schluga Y, Leite LMB, Ribeiro LL, Correa A, Brofman PRS. USE OF TOCILIZUMAB AND MESENCHYMAL STROMAL CELLS IN THE TREATMENT OF SEVERE COVID-19 - A CASE REPORT. Cytotherapy 2021. [PMCID: PMC8079859 DOI: 10.1016/j.jcyt.2021.02.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/04/2022]
Abstract
Background Currently, there is no specific treatment for coronavirus disease, and some drugs and cell-based therapy have been tested as alternatives. This work aims to evaluate the effects of the combined use of humanized recombinant monoclonal antibody capable of binding the IL-6 receptor (Tocilizumab), and umbilical cord tissue-derived mesenchymal stromal cells (UCT-MSC) in the treatment of a patient with severe COVID-19 admitted to the intensive care unit (IUC) and submitted to mechanical ventilation. Methods This study is part of a project approved by the National Research Ethics Commission (CONEP); CAAE: 30833820.8.0000.0020. The patient had a diagnostic criterion for the severe acute respiratory syndrome resulting from infection with SARS-CoV-2 and received two 400 mg doses of tocilizumab, three infusions of 500,000 CTM / kg plus full anticoagulation. TCU-MSC were obtained from healthy donors. The following parameters were evaluated in the pre-infusion of cells (D1), on the day following each infusion (D2, D4, and D6), on the 14th and 60th day after the first infusion (D14 and D60): viral load, immune response (Regulatory T lymphocytes), C-reactive protein level in plasma, oxygen saturation, respiratory rate, total lymphocyte count and subpopulations (platelets, inflammatory cells, and reticulocytes), TGO / TGP, increased prothrombin time, D-dimer, creatinine, troponin. Results The relative viral quantification decreased gradually from 1 (D1) to 0.06 (D6) RdRP / RNApol, undetectable in D14. An increase in the absolute number of total lymphocytes / µL has also been seen to have progressively increased from 281 (D1) to 954.9 (D6) and since then decreased to 641.6 in D60 in the same way as T lymphocytes 148.6 (D1) 642.6 (D6) 607.4 (D14) 485.7 (D60), CD4 T lymphocytes, 102 (D1) 481.2 (D6) 459.5 (D14) 358 (D60) and Treg lymphocytes 10.8 (D1) 34 (D6) 29.8 (D14), 25.9 (D60). Plasmablasts, in contrast, decreased from 52 (D1) to 4.5 (D6) to almost undetectable in D60 (0.2). Laboratory tests outside the reference values decreased during the follow-up from D1 to D14 were within the normal parameters at D60. The patient was extubated uneventfully on D6, discharged from the ICU on D10, and the hospital on D14. Conclusion the combined use of tocilizumab and MSC is safe, without adverse effects, and the results of this case report prove to be a promising alternative in the treatment of patients with severe acute respiratory syndrome due to SARS-CoV-2.
Collapse
|
9
|
Daga DR, Marsaro DB, Schaidt B, Fornazari R, Leite LMB, Senegaglia AC, Rebelatto CLK, Brofman PRS. THE IMMUNOMODULATORY EFFECT OF UMBILICAL CORD MESENCHYMAL STEM CELLS PRODUCED UNDER XENO-FREE CONDITIONS. Cytotherapy 2021. [DOI: 10.1016/j.jcyt.2021.02.103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
10
|
Brito HFV, Rebelatto CLK, Senegaglia AC, Fracaro L, Leite LMB, Laskoski LM, Brofman PRS, Locatelli-Dittrich R. EVALUATION OF SAFETY AND EFFICACY OF BONE MARROW-DERIVED MONONUCLEAR CELLS TRANSPLANTATION FOR THE TREATMENT OF CANINE DISTEMPER SEQUELS. Cytotherapy 2021. [DOI: 10.1016/j.jcyt.2021.02.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
11
|
Kupczik F, Rebelatto CLK, Senegaglia AC, Daga DR, Marsaro DB, Shaidt B, Jamur VR, Vaz IM, Boldrini-Leite LM, Brofman PRS. HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS OR MICROFRACTURES ASSOCIATED TO A COLLAGEN MATRIX FOR BILATERAL KNEE CHONDRAL LESIONS REPAIR: A CLINICAL COMPARATIVE STUDY. Cytotherapy 2021. [DOI: 10.1016/j.jcyt.2021.02.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
12
|
Barbosa ML, dos Santos GV, Fracaro L, JR JAV, Nagashima S, Martins APC, De Paula CBV, Ioshii SO, Capriglione LGA, Utumi PH, Boldrini-Leite LM, Brofman PRS, Rebelatto CLK. HISTOLOGICAL EVALUATION OF CHONDRAL LESION IN RABBIT'S KNEE JOINTS TREATED WITH MESENCHYMAL STEM CELL ASSOCIATED WITH COLLAGEN MEMBRANE. Cytotherapy 2021. [DOI: 10.1016/j.jcyt.2021.02.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
13
|
Villanova JA, Oliveira FM, Wenceslau JC, Bona DL, Fracaro L, Capriglione LGA, Ioshii SO, Brofman PRS, Dittrich RL, Rebelatto CLK. INFLUENCE OF MESENCHYMAL STEM CELLS AND FIBRIN RICH PLASMA MEMBRANE TO REPAIR OSTEOCHONDRAL DEFECTS IN THE RABBIT KNEE. Cytotherapy 2021. [DOI: 10.1016/j.jcyt.2021.02.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
14
|
Villanova Junior JA, Fracaro L, Rebelatto CLK, da Silva AJ, Barchiki F, Senegaglia AC, Dominguez AC, de Moura SAB, Pimpão CT, Brofman PRS, Dittrich RL. Recovery of motricity and micturition after transplantation of mesenchymal stem cells in rats subjected to spinal cord injury. Neurosci Lett 2020; 734:135134. [PMID: 32531527 DOI: 10.1016/j.neulet.2020.135134] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2020] [Revised: 05/27/2020] [Accepted: 06/04/2020] [Indexed: 01/03/2023]
Abstract
The objective was to evaluate the effect of human adipose-derived stem cell (hADSC) infusion on impaired hindlimb function and urinary continence after spinal cord contusion in rats. hADSCs were transplanted into the injured spinal cords of rats 7 and 14 days after injury in two groups (B and C). Group C also received methylprednisolone sodium succinate (MPSS) after 3 h of injury. The control group (group A) did not receive corticoids or stem cells. Voiding and motor performance evaluations were performed daily for 90 days post-transplantation. Cells were labeled with PKH26 or PKH67 for in vitro monitoring. For in vivo screening, the cells were evaluated for bioluminescence. The levels of some cytokines were quantified in different times. Euthanasia was performed 90 days post-transplant. β-tubulin III expression was evaluated in the spinal cord of the animals from all groups. As a result, we observed a recovery of 66.6 % and 61.9 % in urinary continence of animals from groups B and C, respectively. Partial recovery of motor was observed in 23.8 % and 19 % of the animals from groups B and C, respectively. Cells remained viable at the site up to 90 days after transplantation. No significant difference was observed in levels of cytokines and thickness of urinary bladders between groups. A smaller percentage of tissue injury and higher concentrations of neuropils were observed in the spinal cords of the animals from groups B and C than control group. Thus, hADSCs transplantation with or without MPSS, contributed to the improvement in voiding and motor performance of Wistar rats submitted to compressive spinal cord injury.
Collapse
|
15
|
Malaquias MAS, Oyama LA, Jericó PC, Costa I, Padilha G, Nagashima S, Lopes-Pacheco M, Rebelatto CLK, Michelotto PV, Xisto DG, Brofman PRS, Rocco PRM, de Noronha L. Effects of mesenchymal stromal cells play a role the oxidant/antioxidant balance in a murine model of asthma. Allergol Immunopathol (Madr) 2018; 46:136-143. [PMID: 29174587 DOI: 10.1016/j.aller.2017.06.003] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2017] [Revised: 05/30/2017] [Accepted: 06/21/2017] [Indexed: 01/10/2023]
Abstract
Asthma is a heterogeneous disease characterised by chronic airway inflammation. One of the most devastating consequences of this inflammatory process is the generation of reactive oxygen and nitrogen species responsible for oxidative stress. The aim of this study is to analyse the efficiency of treatment with human bone marrow-derived mesenchymal stromal cells (hMSC) in maintaining the oxidative balance in a murine model of allergic asthma by quantifying nitrotyrosine in lung tissues. After confirmation of asthma in the experimental model, samples of lung parenchyma were submitted to immunohistochemical assessment. Intravenous administration of hMSC reduced the levels of nitrotyrosine in the ASTHMA-hMSC group compared to those in the ASTHMA-SAL group. In conclusion, therapeutic administration of hMSC had a beneficial effect on oxidative stress, reducing the levels of nitrotyrosine in lung tissues in a model of allergic asthma.
Collapse
Affiliation(s)
- M A S Malaquias
- Pathology Experimental Laboratory, School of Medicine, Pontifical Catholic University of Paraná, Curitiba, Brazil.
| | - L A Oyama
- Pathology Experimental Laboratory, School of Medicine, Pontifical Catholic University of Paraná, Curitiba, Brazil
| | - P C Jericó
- Pathology Experimental Laboratory, School of Medicine, Pontifical Catholic University of Paraná, Curitiba, Brazil
| | - I Costa
- Laboratory of Pulmonary Investigation, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - G Padilha
- Laboratory of Pulmonary Investigation, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - S Nagashima
- Pathology Experimental Laboratory, School of Medicine, Pontifical Catholic University of Paraná, Curitiba, Brazil
| | - M Lopes-Pacheco
- Laboratory of Pulmonary Investigation, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - C L K Rebelatto
- Experimental Laboratory for Cell Culture, School of Medicine, Pontifical Catholic University of Paraná, Curitiba, Brazil
| | - P V Michelotto
- Experimental Laboratory for Cell Culture, School of Medicine, Pontifical Catholic University of Paraná, Curitiba, Brazil
| | - D G Xisto
- Laboratory of Pulmonary Investigation, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - P R S Brofman
- Experimental Laboratory for Cell Culture, School of Medicine, Pontifical Catholic University of Paraná, Curitiba, Brazil
| | - P R M Rocco
- Laboratory of Pulmonary Investigation, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - L de Noronha
- Pathology Experimental Laboratory, School of Medicine, Pontifical Catholic University of Paraná, Curitiba, Brazil
| |
Collapse
|
16
|
Abreu JPD, Rebelatto CLK, Savari CA, Capriglione LGA, Miyague L, Noronha LD, Amaral VFD. The Effect of Mesenchymal Stem Cells on Fertility in Experimental Retrocervical Endometriosis. Rev Bras Ginecol Obstet 2017; 39:217-223. [PMID: 28399593 PMCID: PMC10309402 DOI: 10.1055/s-0037-1601484] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Abstract
Purpose To evaluate the effect of mesenchymal stem cells (MSCs) on fertility in experimental retrocervical endometriosis. Methods A total of 27 New Zealand rabbits were divided into three groups: endometriosis, in which endometrial implants were created; mesenchymal, in which MSCs were applied in addition to the creation of endometrial implants; and control, the group without endometriosis. Fisher's exact test was performed to compare the dichotomous qualitative variables among the groups. The quantitative variables were compared by the nonparametric Mann-Whitney and Kruskal-Wallis tests. The Mann-Whitney test was used for post-hoc multiple comparison with Boniferroni correction. Results Regarding the beginning of the fertile period, the three groups had medians of 14 ± 12.7, 40 ± 5, and 33 ± 8.9 days respectively (p = 0.005). With regard to fertility (number of pregnancies), the endometriosis and control groups showed a rate of 77.78%, whereas the mesenchymal group showed a rate of 11.20% (p = 0.015). No differences in Keenan's histological classification were observed among the groups (p = 0.730). With regard to the macroscopic appearance of the lesions, the mesenchymal group showed the most pelvic adhesions. Conclusion The use of MSCs in endometriosis negatively contributed to fertility, suggesting the role of these cells in the development of this disease.
Collapse
Affiliation(s)
- Jaqueline Pedroso de Abreu
- Center for Health and Biological Sciences, Pontifícia Universidade Católica do Paraná (PUC-PR), Escola de Medicina, Curitiba, Paraná, Brazil
| | | | - Carolina Antunes Savari
- Center for Health and Biological Sciences, Pontifícia Universidade Católica do Paraná (PUC-PR), Escola de Medicina, Curitiba, Paraná, Brazil
| | | | - Lye Miyague
- Center for Health and Biological Sciences, Escola de Ciências Agrárias e Medicina Veterinária, PUC-PR, Curitiba, Paraná, Brazil
| | - Lucia de Noronha
- Center for Health and Biological Sciences, Pontifícia Universidade Católica do Paraná (PUC-PR), Escola de Medicina, Curitiba, Paraná, Brazil
| | - Vivian Ferreira do Amaral
- Department of Obstetrics and Gynecology, Universidade Federal do Paraná (UFPR), Curitiba, Paraná, Brazil
| |
Collapse
|
17
|
Borgonovo T, Solarewicz MM, Vaz IM, Daga D, Rebelatto CLK, Senegaglia AC, Ribeiro E, Cavalli IJ, Brofman PS. Emergence of clonal chromosomal alterations during the mesenchymal stromal cell cultivation. Mol Cytogenet 2015; 8:94. [PMID: 26628918 PMCID: PMC4666177 DOI: 10.1186/s13039-015-0197-5] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2015] [Accepted: 11/20/2015] [Indexed: 02/07/2023] Open
Abstract
Background Use of human mesenchymal stromal cells (MSCs) is a promising strategy for cell therapy in injured tissues recovery. However, MSCs acquire genetic changes when cultivated in vitro that make them more susceptible to undergo neoplastic transformation. Therefore, genomic integrity of stem cells should be monitored carefully for the use in basic research and clinical trials, including karyotype analysis to confirm the absence of genetic instability. Here, we report a case of a male 67-year-old patient selected to join the study: “Autologous transplantation of mesenchymal cells for treatment of severe and refractory ischemic cardiomyopathy”. He underwent nephrectomy for malignant tumor on the right kidney. Cytogenetic analysis on a bone marrow sample showed a normal karyotype: 46,XY[20]. However, the MSC at second passage showed a hyperdiploid clone, with clonal trisomies of chromosomes 4, 5, 10 and X. In order to investigate more, another sample from the same patient was used for a second cultivation and, at third passage, these cells showed a clonal translocation t(9;18)(p24;q11). The recurrent aberrations in MSC may indicate the beginning of a spontaneous transformation in culture, so, these cells were not used for cell therapy. Several analyses were performed at the Center for Cell Technology (152 samples), however this was the only case to show clonal cytogenetic abnormalities. Interestingly, two distinct clonal alterations were seen in two parallel cell cultivations from the same patient, suggesting a propensity for genetic instability. This highlights the need to evaluate these cells on a case-by-case basis, especially in patients with a history of cancer. Although there is controversy about the use of cells with cytogenetic abnormality for therapy, because their tumorigenic doubtful potential, we decided against the use of these cells for regenerative medicine. Case presentation Here, we report a case of a male 67-year-old patient selected to join the study: “Autologous transplantation of mesenchymal cells for treatment of severe and refractory ischemic cardiomyopathy”. He underwent nephrectomy for malignant tumor on the right kidney. Cytogenetic analysis on a bone marrow sample showed a normal karyotype: 46,XY[20]. However, the MSC at second passage showed a hyperdiploid clone, with clonal trisomies of chromosomes 4, 5, 10 and X. In order to investigate more, another sample from the same patient was used for a second cultivation and, at third passage, these cells showed a clonal translocation t(9;18)(p24;q11). The recurrent aberrations in MSC may indicate the beginning of a spontaneous transformation in culture, so, these cells were not used for cell therapy. Several analyses were performed at the Center for Cell Technology(152 samples), however this was the only case to show clonal cytogenetic abnormalities. Interestingly, two distinct clonal alterations were seen in two parallel cell cultivations from the same patient, suggesting a propensity for genetic instability. This highlights the need to evaluate these cells on a case-by-case basis, especially in patients with a history of cancer. Conclusions Although there is controversy about the use of cells with cytogenetic abnormality for therapy, because their tumorigenic doubtful potential, we decided against the use of these cells forregenerative medicine.
Collapse
Affiliation(s)
- Tamara Borgonovo
- Centro de Tecnologia Celular (CTC), Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná Brazil ; Cytogenetic Laboratory of Centro de Tecnololgia Celular (CTC), PUCPR, Curitiba, Brazil
| | - Maria Marlene Solarewicz
- Centro de Tecnologia Celular (CTC), Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná Brazil ; Cytogenetic Laboratory of Centro de Tecnololgia Celular (CTC), PUCPR, Curitiba, Brazil
| | - Isadora May Vaz
- Centro de Tecnologia Celular (CTC), Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná Brazil ; Cytogenetic Laboratory of Centro de Tecnololgia Celular (CTC), PUCPR, Curitiba, Brazil
| | - Debora Daga
- Centro de Tecnologia Celular (CTC), Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná Brazil
| | | | | | - Enilze Ribeiro
- Departamento de Genética, Universidade Federal do Paraná (UFPR), Curitiba, Paraná Brazil
| | - Iglenir João Cavalli
- Departamento de Genética, Universidade Federal do Paraná (UFPR), Curitiba, Paraná Brazil
| | - Paulo Slud Brofman
- Centro de Tecnologia Celular (CTC), Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná Brazil
| |
Collapse
|
18
|
Capriglione LGA, Barchiki F, Ottoboni GS, Miyague NI, Suss PH, Rebelatto CLK, Pimpão CT, Senegaglia AC, Brofman PR. Comparison of two surgical techniques for creating an acute myocardial infarct in rats. Braz J Cardiovasc Surg 2015; 29:505-12. [PMID: 25714202 PMCID: PMC4408811 DOI: 10.5935/1678-9741.20140075] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2013] [Accepted: 05/26/2014] [Indexed: 11/20/2022] Open
Abstract
Objective To perform a comparative assessment of two surgical techniques that are used
creating an acute myocardial infarc by occluding the left anterior descending
coronary artery in order to generate rats with a left ventricular ejection
fraction of less than 40%. Methods The study was completely randomized and comprised 89 halothane-anaesthetised rats,
which were divided into three groups. The control group (SHAM) comprised fourteen
rats, whose left anterior descending coronary artery was not occluded. Group 1
(G1): comprised by 35 endotracheally intubated and mechanically ventilated rats,
whose left anterior descending coronary artery was occluded. Group 2 (G2):
comprised 40 rats being manually ventilated using a nasal respirator whose left
anterior descending coronary artery was occluded. Other differences between the
two techniques include the method of performing the thoracotomy and removing the
pericardium in order to expose the heart, and the use of different methods and
suture types for closing the thorax. Seven days after surgery, the cardiac
function of all surviving rats was determined by echocardiography. Results No rats SHAM group had progressed to death or had left ventricular ejection
fraction less than 40%. Nine of the 16 surviving G1 rats (56.3%) and six of the 20
surviving G2 rats (30%) had a left ventricular ejection fraction of less than
40%. Conclusion The results indicate a tendency of the technique used in G1 to be better than in
G2. This improvement is probably due to the greater duration of the open thorax,
which reduces the pressure over time from the surgeon, allowing occlusion of left
anterior descending coronary artery with higher accuracy.
Collapse
Affiliation(s)
| | - Fabiane Barchiki
- Pontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Stramandinoli-Zanicotti RT, Carvalho AL, Rebelatto CLK, Sassi LM, Torres MF, Senegaglia AC, Boldrinileite LM, Correa-Dominguez A, Kuligovsky C, Brofman PRS. Brazilian minipig as a large-animal model for basic research and stem cell-based tissue engineering. Characterization and in vitro differentiation of bone marrow-derived mesenchymal stem cells. J Appl Oral Sci 2014; 22:218-27. [PMID: 25025563 PMCID: PMC4072273 DOI: 10.1590/1678-775720130526] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2013] [Accepted: 01/20/2014] [Indexed: 01/22/2023] Open
Abstract
Stem cell-based regenerative medicine is one of the most intensively researched
medical issues. Pre-clinical studies in a large-animal model, especially in swine or
miniature pigs, are highly relevant to human applications. Mesenchymal stem cells
(MSCs) have been isolated and expanded from different sources.
Collapse
Affiliation(s)
| | - André Lopes Carvalho
- Department of Oncology, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil
| | | | - Laurindo Moacir Sassi
- Service of Oral and Maxillofacial Surgery, Erasto Gaertner Hospital, Curitiba, PR, Brazil
| | - Maria Fernanda Torres
- Laboratory of Experimental Surgery, Positivo University/Department of Anatomy, Federal University of Paraná (UFPR), Curitiba, PR, Brazil., Curitiba, PR, Brazil
| | | | | | | | - Crisciele Kuligovsky
- Laboratory of Basic Biology of Stem Cells, Carlos Chagas Institute, Curitiba, PR, Brazil
| | | |
Collapse
|
20
|
Silva AC, Percegona LS, França AL, Dos Santos TM, Perini CC, González P, Rebelatto CLK, Câmara NOS, Aita CAM. Expression of pancreatic endocrine markers by mesenchymal stem cells from human adipose tissue. Transplant Proc 2013; 44:2495-6. [PMID: 23026628 DOI: 10.1016/j.transproceed.2012.07.036] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Mesenchymal stem cells (MSCs) from human adipose tissue have a great potential for use in cell therapy due to their ease of isolation, expansion, and differentiation, besides the relative acceptance from the ethical point of view. Our intention was to isolate and promote in vitro expansion and differentiation of MSCs from human adipose tissue into cells with a pancreatic endocrine phenotype. Human adipose tissue obtained from patients undergoing abdominal dermolipectomy was digested with type I collagenase. MSCs isolated by plastic adherence and characterized by cytochemistry and FACS were expanded in vitro. MSC differentiation into an endocrine phenotype was induced over 2 to 4 months with high glucose (25 mmol/L) media containing nicotinamide, exendin-4, and 2-mercaptoethanol. Insulin and glucagon expressions were analyzed by immunofluorescence. Cells isolated from human adipose tissue and expanded in vitro expressed MSC markers as confirmed by FACS and cytochemistry. Insulin but not glucagon production by differentiated cells was demonstrated by immunofluorescence. MSCs isolated from human adipose tissue were induced to differentiate in vitro into an endocrine phenotype that expressed insulin.
Collapse
Affiliation(s)
- A C Silva
- Centro de Ciências Biológicas e da Saúde, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil
| | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Aguiar AMD, Kuligovski C, Costa MTBAD, Stimamiglio MA, Rebelatto CLK, Senegaglia AC, Brofman PRS, Dallagiovanna B, Goldenberg S, Correa A. Alkaline phosphatase-positive cells isolated from human hearts have mesenchymal stem cell characteristics. ACTA ACUST UNITED AC 2011. [DOI: 10.4236/scd.2011.13008] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
22
|
Senegaglia AC, Brofman PRS, Aita CAM, Dallagiovanna B, Rebelatto CLK, Hansen P, Barchiki F, Krieger MA. Formação in vitro de túbulos capilares a partir de células de sangue de cordão umbilical humano com perspectivas para aplicação terapêutica. Braz J Cardiovasc Surg 2008; 23:467-73. [DOI: 10.1590/s0102-76382008000400003] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2008] [Accepted: 09/23/2008] [Indexed: 11/21/2022] Open
|
23
|
Carvalho KAT, Guarita-Souza LC, Hansen P, Rebelatto CLK, Senegaglia AC, Miyague N, Olandoski M, Francisco JC, Furuta M, Gremski W. Cell transplantation after the coculture of skeletal myoblasts and mesenchymal stem cells in the regeneration of the myocardium scar: an experimental study in rats. Transplant Proc 2006; 38:1596-602. [PMID: 16797364 DOI: 10.1016/j.transproceed.2006.03.023] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2004] [Indexed: 11/26/2022]
Abstract
UNLABELLED In myocardial infarction and Chagas's disease, some physiopathological aspects are common: cardiomyocyte loss due to ischemia leads to a reduction of contractility and heart function. Different cells have been proposed for cellular cardiomioplasty. OBJECTIVE Our goal was to evaluate the method of co-culture of skeletal muscle (SM) and mesenchymal stem cells (MSC) for cell therapy of heart failure in Chagas's disease (CD) and myocardium postinfarction (MI). METHODS For MI, 39 rats completed the study at 1 month. Seventeen rats received cell therapy into the scar and 22 rats only medium. For CD, 15 rats completed the study at 1 month including 7 that received cell therapy and eight followed the natural evolution. All animals underwent ecocardiographic analysis at baseline and 1 month. Left ventricular, ejection fraction, end systolic, and end dyastolic volume were registered and analyzed by ANOVA. The co-culture method of SM and MSC was performed at 14 days (DMEM, with 15% FCS, 1% antibiotic, IGF-I, dexamethasone). Standard stain analysis was performed. RESULTS For MI ejection fraction in the animals that received the co-cultured cells increased from 23.52+/-8.67 to 31.45+/-8.87 (P=.006) versus the results in the control group: 26.68+/-6.92 to 22.32+/-6.94 (P=.004). For CD, ejection fraction in animals that received the co-cultured cells increased from 31.10+/-5.78 to 53.37+/-5.84 (P<.001) versus the control group values of 36.21+/-3.70 to 38.19+/-7.03 (P=0.426). Histopathological analysis of the animals receiving co-cultured cells demonstrated the presence of myogenesis and angiogenesis. CONCLUSION The results validated the product of SM and MSC co-cultures for treatment of diseases.
Collapse
Affiliation(s)
- K A T Carvalho
- Pontificia Universidade Católica - Paraná; Bioprocess's Engineer of the Biotechnology Division of UFPR, Brazil.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
de Almeida SM, Rebelatto CLK, Queiroz-Telles F, Werneck LC. Major histocompatibility complex and central nervous system involvement by paracoccidioidomycosis. J Infect 2005; 51:140-3. [PMID: 16038765 DOI: 10.1016/j.jinf.2004.06.008] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/21/2004] [Indexed: 11/18/2022]
Abstract
Paracoccidioidomycosis (PCM) is a chronic granulomatous infectious disease, whose etiologic agent is the fungus Paracoccidioides brasiliensis. The central nervous system (CNS) involvement with paracoccidioidomycosis (NPCM) occurs more frequently than has been admitted in the past. There are some major histocompatibility complex antigen association studies with systemic paracoccidioidomycosis. Some indicate a positive association with HLA antigens, but there is no study with the involvement of the CNS. To investigate why not all cases of systemic PCM show the involvement of the CNS and whether genetic factors are involved, we studied 6 patients with NPCM, from the neuroinfection outpatient clinic. The patients were typed for class I and class II antigens by a microlymphocytoxity standard test. The HLA antigen frequencies found in this study in patients with NPCM were not different from the alleles frequencies observed in the Paraná population.
Collapse
Affiliation(s)
- Sergio Monteiro de Almeida
- Neurology Unit, Hospital de Clínicas, Federal University of Paraná, Especialidade de Neurologia, Rua General Carneiro, 181, sala 1236, 80060-900 Curitiba, PR, Brazil.
| | | | | | | |
Collapse
|
25
|
Carvalho KAT, Guarita-Souza LC, Rebelatto CLK, Senegaglia AC, Hansen P, Mendonça JGR, Cury CC, Francisco JC, Brofman PRS. Could the coculture of skeletal myoblasts and mesenchymal stem cells be a solution for postinfarction myocardial scar? Transplant Proc 2005; 36:991-2. [PMID: 15194344 DOI: 10.1016/j.transproceed.2004.03.056] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Currently two lines of research have been proposed for treatment of heart failure in an attempt to address its main cause: skeletal myoblast (SM) transplants, which increase the contractile muscular mass, and mesenchymal stem cell (MSC) transplants, which increase neoangiogenesis. The objective of this study was to establish methods whereby cocultures of SM and MSC proliferate and expand, making possible the interaction of these cell types prior to their transplantation to the myocardium. Seeking to support the survival of these cells after myocardial transplantation and achieve subsequent functional improvement, SM and MSC from 10 rats were isolated and cultivated in DMEM medium supplemented with 15% fetal calf serum, 1% ATB, and growth factors. Following plating in variable proportions of satellite cells/mononuclear cells namely 2:1, 1:1, 1:2, morphological observations were made regarding cell survival, adhesion to substrate, and confluence. After 48 hours nonadherent cells were aspirated from the flasks, leaving the adherent cells, SM, and MSC. The better level of cell proliferation was observed with the proportion 2:1 cocultivated at a concentration of 5 x 10(5)/mL for 14 days. The results were satisfactory; the cell production was up to 10(8), increasing the chances of transplant success after myocardial infarction. Transplants with this model are ongoing.
Collapse
|
26
|
Carvalho KAT, Guarita-Souza LC, Rebelatto CLK, Senegaglia AC, Hansen P, Mendonca JGR, Cury CC, Francisco JC, Brofman PRS. Aneural culture of rat myoblasts for myocardial transplant. Transplant Proc 2004; 36:1023-4. [PMID: 15194356 DOI: 10.1016/j.transproceed.2004.04.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Due to the peculiar characteristics of skeletal muscle, myoblast transplants have emerged as a therapy for cardiomyopathy, particularly after myocardial infarction. The objectives of this study were to define the mean time of cultivation necessary to obtain a cellular concentration of 10(6) to expand the mass for transplant, and to identify the proliferation phase of myoblasts. Ten myoblast cultures were performed using newborn Wistar rats. The isolation method used enzymatic dissociation in culture medium (HAM-F12 and 199) supplement with basic-fibroblast growth factor (b-FGF) and insulin growth factor (IGF-I). The mean cultivation time to obtain the desired concentration of 10(6) was 7 days, with expansion of up to 10(8)/g. When b-FGF was used, the cellular yield was approximately 10(7), with IGF-I the cellular yield was approximately 10(8), independent of the medium. We concluded that IGF-I is the better option for mass cellular expansion of myoblasts for application in myocardial transplants.
Collapse
|